🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Enanta Pharmaceuticals, Inc.

ENTA Healthcare
$14.76 +$0.67 (4.72%)
Market Cap: $430.04 M
Gurus Holding
2
Popularity Rank
#3741
% of Shares Held
2.80%
Net Activity (Q2 2026)
-$2.52 M

Guru Ownership Trend

Guru Analysis for Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals, Inc. (ENTA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.03 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.52 M net outflow during the quarter.

On the selling side, Cliff Asness reduced exposure by 18.0%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$0
Total Buy Value
New Buys 0
Additions 0
-$2.52 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
0

FAQs for Enanta Pharmaceuticals, Inc. (ENTA)

Major holders include Renaissance Technologies (RenTech) ($8.13 M), Cliff Asness ($3.75 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 814,470 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.52 M, with 0 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ENTA. The total reported sell value was $2.52 M.

No tracked managers opened new positions or increased their holdings in ENTA during the most recent reporting period.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -16.2% 557,600 $8.13 M Q2 2026
0.00% Reduce -18.0% 256,870 $3.75 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form